Halts

NIH Halts Trial of Convalescent Plasma for Mild COVID-19

by
NIH Halts Trial of Convalescent Plasma for Mild COVID-19

By Robert Preidt HealthDay Reporter WEDNESDAY, March 3, 2021 (HealthDay News) — A clinical trial evaluating the use of convalescent plasma in patients with mild to moderate COVID-19 symptoms has been halted because the treatment didn’t benefit them, according to the U.S. National Institutes of Health. Convalescent plasma (also called “survivor’s plasma”) is derived … Read more

FDA Halts Approval for Plasma to Treat COVID-19

by
FDA Halts Approval for Plasma to Treat COVID-19

Aug. 20, 2020 — U.S. Food and Drug Administration’s emergency approval of blood plasma as a COVID-19 treatment was put on hold last week after senior federal health officials said data supporting the therapy was too weak. More data is under review and the approval could still be issued in the near future, according to … Read more